Pathological and clinical characteristics of late-onset oligomeganephronia based on a histomorphometric study

Ya-Li Ren1, Yang Li2, Jie Gao3

  • 1Laboratory of Electron Microscopy, Pathological Center, Peking University First Hospital, No. 8, Xishiku Street, Beijing, 100034, People's Republic of China.

BMC Nephrology
|March 16, 2023
PubMed
Abstract

Insights

Late-onset oligomeganephronia (OMN) is a rare kidney disease. This study defines diagnostic criteria and reveals OMN involves enlarged glomeruli, tubular injury, and slower progression, offering new insights into this condition.

Area of Science:

  • Nephrology
  • Pathology
  • Histomorphometry

Background:

  • Late-onset oligomeganephronia (OMN) is a rare chronic kidney disease.
  • Current diagnostic criteria for OMN are lacking.
  • This study investigates the clinicopathological features of late-onset OMN.

Purpose of the Study:

  • To establish quantitative diagnostic criteria for late-onset OMN.
  • To explore the clinicopathological characteristics of late-onset OMN.
  • To differentiate OMN from other kidney diseases with similar presentations.

Main Methods:

  • Retrospective review of patients with enlarged and sparse glomeruli.
  • Histomorphometric analysis of glomeruli and kidney tissue.
  • Comparison with age- and sex-matched controls with thin basement membrane nephropathy.

Main Results:

  • Established cut-off values for glomerulomegaly (>211.53 μm) and rarity (<2.81/mm²).
  • Diagnosed seven adult cases of late-onset OMN with characteristic features including glomerular hypertrophy, segmental sclerosis, and proximal tubule dilation.
  • Observed wider glomerular foot process width in OMN patients compared to controls (634.02 nm vs. 472.54 nm).

Conclusions:

  • Late-onset OMN is a distinct clinicopathological entity.
  • Characterized by hypertrophy of sparsely distributed nephrons and relatively slow clinical progression.
  • Histomorphometric analysis provides crucial diagnostic criteria for OMN.

Related Concept Videos

Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...